Subsequently, ATRA was found to induce myeloid differentiation in APL cell lines, as well as the HL-60 AML cell line, leading to the introduction of ATRA-based therapy for PML-RARα associated APL in 1985 (Huang et al., 1988). The gene discussed is PML; the disease is acute promyelocytic leukemia.